Kolkata: The IPO of the Ahmedabad-based agrochemical company, GSP Crop Science intends to mobilise Rs 400 crore. The subscription process will close on March 18. The company has fixed the price band for this IPO at Rs 304-320. As much as 50% of the issue has been reserved for Qualified Institutional Buyers, 35% for retail investors and 15% for non-institutional investors.
This public issue comprises a mix of a fresh issue worth Rs 240 crore and an Offer for Sale part to raise Rs 160 crore. The management intends to utilise the issue proceeds to repay debt and meet general corporate requirements. The minimum lot size for a retail investor in 46 shares. Valuation risks, inconsistent growth in revenue and dependence on a few suppliers for raw materials have been pointed out as the risk factors for the issue.
GSP Crop Science IPO GMP
According to investorgain, in early morning of March 17, the second day of the bidding process, GSP Crop Science IPO GMP stood at Rs 0. Therefore, the estimated listing prices of GSP Crop Science share will be Rs 320 and the listing gain will be 0.00%. The GMP of this issue has never been more than zero. However, GMP is an unofficial indicator, can be very volatile and cannot guarantee listing gain.
GSP Crop Science IPO price band, lot size
The GSP Crop Science IPO price band is Rs 304-320 per share. For a retail investor, the lot size for an application is 46 for which an application amount of Rs 14,720 will be required based on the upper end of the price band. The lot size investment for sNII investors is 14 lots or 644 shares and that for bNII category of investors is 68 lots or 3,128 shares. Equirus Capital is the book running lead manager and MUFG Intime India is the registrar of the issue.
GSP Crop Science IPO key dates
Bid closes: March 18
Allotment: March 20
Refund: March 23
Credit of shares: March 23
Listing: March 24, 2026
GSP Crop Science business and financials
GSP Crop Science develops and manufactures herbicides, fungicides, insecticides, and plant growth regulators. The company operates four manufacturing plants with a combined capacity of 15,120 MTPA (technical) and 43,672 MTPA (formulation). The company’s revenue for FY25 stood at Rs 1,287.38 crore, an increase from Rs 1,152.16 crore in FY24. In the same period the net profit rose from Rs 61.28 crore to Rs 82.13 crore — a surge of 34%.
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, InvITs and any form of alternative investment instruments and crypto assets.)